Herbst Kinsky accompanies Biogena Group Invest during its listing at the Vienna Stock Exchange
Herbst Kinsky is pleased to announce that its team has advised Biogena Group Invest AG during the listing at the Vienna Stock Exchange. The application for inclusion of the company’s shares in the direct market of the Vienna MTF of Vienna Stock Exchange was filed on November 24, 2020. The shares were admitted to trading on November 27, 2020. Wiener Privatbank acts as paying agent in the course of this listing.
The Biogena Group is an operationally active group of companies in the field of high-quality micronutrients and health, in which Biogena Group Invest AG holds a stake. The business activity of the Biogena Group is the development and distribution of products and services in the field of health and nutrition. The focus is particularly on iron, mineral and osteoporosis product innovations and new integrated solutions in the field of workplace health promotion. The Biogena Group is Austria’s market leader in the field of dietary supplements and high-quality micronutrients, currently employs more than 360 people and delivers to over 40 countries worldwide. The last consolidated annual turnover was 50 million euros.
“With innovative approaches and practical solutions Herbst Kinsky and the team around Johannes Frank advised us professionally and pragmatically during the listing. We are pleased to be able to use this new capital in the company’s history to position Biogena on the capital market and to give investors the opportunity to participate in Biogena’s success,” said Dr. Albert Schmidbauer, CEO and founder of Biogena Group.